A detailed history of Spire Wealth Management transactions in Biovie Inc. stock. As of the latest transaction made, Spire Wealth Management holds 1,496 shares of BIVI stock, worth $598. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,496
Previous 1,500 0.27%
Holding current value
$598
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$0.53 - $1.89 $2 - $7
-4 Reduced 0.27%
1,496 $0
Q4 2023

Feb 06, 2024

BUY
$1.22 - $5.24 $610 - $2,620
500 Added 50.0%
1,500 $1,000
Q3 2023

Nov 08, 2023

BUY
$2.75 - $5.17 $1,925 - $3,619
700 Added 233.33%
1,000 $3,000
Q4 2022

Feb 03, 2023

BUY
$3.86 - $13.38 $1,158 - $4,014
300 New
300 $2,000

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $12.1M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.